SCIENTIST HOME FTR HLTH (SHFH) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SHFH SEC filings page.
SCIENTIST HOME FTR HLTH (SHFH) reported $204K in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
External financing is carrying a loss-making operation while sub-1.0x liquidity leaves little short-term balance-sheet slack
FY2025’s cash conversion profile is close to the accounting result: net income was-$232K while operating cash flow was-$248K , so the loss largely translated into an actual cash drain rather than reflecting mainly noncash charges. The free-cash-flow shortfall reached-$323K , versus operating cash flow of-$248K , showing investing outlays widened the cash gap beyond day-to-day operations.
A 0.9x current ratio indicates current assets do not fully cover current liabilities, leaving limited short-term balance-sheet flexibility. Total liabilities were
The financing inflow of
Financial Health Signals
SCIENTIST HOME FTR HLTH does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
SCIENTIST HOME FTR HLTH scores 274.58, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($244.3M) relative to total liabilities ($531K). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
SCIENTIST HOME FTR HLTH reported a net loss of $232K while operations used $248K of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
SCIENTIST HOME FTR HLTH generated $83K in revenue in Q2 2026. This represents an increase of 162.7% from the same quarter a year earlier. Against the prior quarter it is down 56.1%.
SCIENTIST HOME FTR HLTH's EBITDA was -$94K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 146.8% from the same quarter a year earlier. Against the prior quarter it is up 4.3%.
SCIENTIST HOME FTR HLTH reported -$98K in net income in Q2 2026. This represents a decrease of 163.0% from the same quarter a year earlier. Against the prior quarter it is up 4.1%.
Cash & Balance Sheet
SCIENTIST HOME FTR HLTH held $9K in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Not reported for Q2 2026.
Margins & Returns
SCIENTIST HOME FTR HLTH's gross margin was 35.1% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 7.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.8 percentage points.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not shown for Q2 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.
Not reported for Q2 2026.
Capital Allocation
None of these metrics is reported for Q2 2026.
SHFH Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $83K+162.7% | $189K+321.1% | $88K | $40K-33.3% | $32K | $45K | N/A | $59K |
| Cost of Revenue | $0 | $0 | -$22K | $24K-28.6% | $0 | $0 | N/A | $33K |
| Gross Profit | $29K+115.0% | $59K+200.0% | $33K | $16K-39.1% | $14K | $20K | N/A | $26K |
| SG&A Expenses | $127K+145.6% | $161K+1169.3% | $185K | $64K+161.3% | $52K | $13K | N/A | $24K |
| Operating Income | -$98K-156.5% | -$102K-1559.4% | -$153K | -$48K-2581.6% | -$38K | $7K | N/A | $2K |
| EBITDA | -$94K-146.8% | -$98K-1506.1% | N/A | N/A | -$38K | $7K | N/A | N/A |
| Income Tax | $0+100.0% | $0-100.0% | $0 | $0-100.0% | -$935 | $935 | N/A | $2K |
| Net Income | -$98K-163.0% | -$102K-1784.6% | -$153K | -$48K-27440.0% | -$37K | $6K | N/A | $175 |
| EPS (Diluted) | $0.00 | $0.00 | -$0.01 | $0.00 | $0.00 | $0.00 | N/A | $0.00 |
| Diluted Shares (Avg) | 24M+0.9% | 24M+1.0% | N/A | 24M+102.4% | 24M | 23M | N/A | 12M |
Not reported in any period shown, so not listed: R&D Expenses, Interest Expense, EPS (Basic).
SHFH Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $530K+361.9% | $559K+2751.5% | $644K+2932.6% | $723K+1458.9% | $115K | $20K | $21K | $46K |
| Current Assets | $125K+9.2% | $132K+573.2% | $192K+804.8% | $326K | $115K | $20K | $21K | N/A |
| Cash & Equivalents | $9K-91.9% | $15K-5.0% | $69K+269.9% | $276K+1353.6% | $111K | $16K | $19K | $19K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $34K+918.3% | $31K+806.8% | $34K+1194.5% | $2K | $3K | $3K | $3K | N/A |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $616K+875.2% | $547K+2697.1% | $531K+1847.2% | $456K+1124.4% | $63K | $20K | $27K | $37K |
| Current Liabilities | $340K+438.6% | $252K+1188.5% | $214K+686.5% | $123K | $63K | $20K | $27K | N/A |
| Non-Current Liabilities | $276K | $295K | $317K | $333K | $0 | $0 | $0 | N/A |
| Total Equity | -$86K-267.5% | $11K+42222.2% | $113K+1983.6% | $267K+2822.9% | $52K | $27 | -$6K | $9K |
| Retained Earnings | -$447K-868.1% | -$349K-3809.6% | -$247K-1546.9% | -$94K | -$46K | -$9K | -$15K | N/A |
Not reported in any period shown, so not listed: Accounts Receivable, Goodwill, Long-Term Debt.
SHFH Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
SHFH Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.1%-7.8pp | 31.3%-12.6pp | 37.0% | 40.6%-3.9pp | 42.9% | 43.9% | N/A | 44.5% |
| Operating Margin | -118.1% | -54.1%-69.7pp | -173.4% | -120.8% | -120.9% | 15.6% | N/A | 3.3% |
| Net Margin | -118.1% | -54.1%-67.6pp | -173.4% | -120.8% | -117.9% | 13.5% | N/A | 0.3% |
| Return on Equity | N/A | -893.2%-23334.0pp | -134.7% | -17.9%-19.8pp | -72.2% | 22440.7% | N/A | 1.9% |
| Return on Assets | -18.5%+14.0pp | -18.3%-49.2pp | -23.7% | -6.6%-7.0pp | -32.4% | 30.9% | N/A | 0.4% |
| Current Ratio | 0.37-1.4x | 0.52-0.5x | 0.90+0.1x | 2.64 | 1.82 | 1.00 | 0.78 | N/A |
| Debt-to-Equity | N/A | 47.90-676.8x | 4.68 | 1.71-2.4x | 1.23 | 724.74 | N/A | 4.08 |
| Asset Turnover | 0.16-0.1x | 0.34-1.9x | 0.14 | 0.05-1.2x | 0.28 | 2.29 | N/A | 1.28 |
Not reported in any period shown, so not listed: FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.
Note: The current ratio is below 1.0 (0.90), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where SCIENTIST HOME FTR HLTH Ranks
Frequently Asked Questions
What is SCIENTIST HOME FTR HLTH's annual revenue?
SCIENTIST HOME FTR HLTH (SHFH) reported $204K in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Is SCIENTIST HOME FTR HLTH profitable?
No, SCIENTIST HOME FTR HLTH (SHFH) reported a net income of -$232K in fiscal year 2025.
What is SCIENTIST HOME FTR HLTH's EBITDA?
SCIENTIST HOME FTR HLTH (SHFH) had EBITDA of -$230K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is SCIENTIST HOME FTR HLTH's gross margin?
SCIENTIST HOME FTR HLTH (SHFH) had a gross margin of 40.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is SCIENTIST HOME FTR HLTH's return on equity (ROE)?
SCIENTIST HOME FTR HLTH (SHFH) has a return on equity of -204.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is SCIENTIST HOME FTR HLTH's free cash flow?
SCIENTIST HOME FTR HLTH (SHFH) recorded an outflow of $323K in free cash flow during fiscal year 2025. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is SCIENTIST HOME FTR HLTH's operating cash flow?
SCIENTIST HOME FTR HLTH (SHFH) recorded an outflow of $248K in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are SCIENTIST HOME FTR HLTH's total assets?
SCIENTIST HOME FTR HLTH (SHFH) had $644K in total assets as of fiscal year 2025, including both current and long-term assets.
What are SCIENTIST HOME FTR HLTH's capital expenditures?
SCIENTIST HOME FTR HLTH (SHFH) invested $75K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is SCIENTIST HOME FTR HLTH's current ratio?
SCIENTIST HOME FTR HLTH (SHFH) had a current ratio of 0.90 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is SCIENTIST HOME FTR HLTH's debt-to-equity ratio?
SCIENTIST HOME FTR HLTH (SHFH) had a debt-to-equity ratio of 4.68 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is SCIENTIST HOME FTR HLTH's return on assets (ROA)?
SCIENTIST HOME FTR HLTH (SHFH) had a return on assets of -36.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is SCIENTIST HOME FTR HLTH's P/E ratio?
SCIENTIST HOME FTR HLTH (SHFH) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $244.3M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is SCIENTIST HOME FTR HLTH's price-to-sales ratio?
SCIENTIST HOME FTR HLTH (SHFH) trades at 612x sales, its market capitalization divided by revenue of $399K revenue, trailing 12 months to June 30, 2026. The market capitalization is $244.3M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does SCIENTIST HOME FTR HLTH's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, SCIENTIST HOME FTR HLTH (SHFH) held $69K in cash, cash equivalents and investments, and reported an operating cash outflow of $248K over that year. Dividing the one by the other, the reported balance equals about 3 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
What is SCIENTIST HOME FTR HLTH's Altman Z-Score?
SCIENTIST HOME FTR HLTH (SHFH) has an Altman Z-Score of 274.58, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Are SCIENTIST HOME FTR HLTH's earnings high quality?
SCIENTIST HOME FTR HLTH (SHFH) reported a net loss of $232K while operations used $248K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.